Tadekinig alfa
Tadekinig alfa Uses, Dosage, Side Effects, Food Interaction and all others data.
Tadekinig alfa is under investigation in clinical trial NCT03113760 (Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency).
| Trade Name | Tadekinig alfa |
| Generic | Tadekinig alfa |
| Tadekinig alfa Other Names | Tadekinig alfa |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Tadekinig alfa
